FUSN(Delisted)
Fusion·NASDAQ
--
--(--)
FUSN Profile
Fusion Pharmaceuticals Inc.
A clinical-stage oncology company that developing next-generation radiopharmaceuticals as precision medicines
270 Longwood Rd., S., Hamilton, Ontario, Canada L8P 0A6
--
Fusion Pharmaceuticals Inc. was incorporated in December 2014 under the laws of the Ontario Business Corporation Act. The company is a clinical-stage oncology company dedicated to the development of next-generation radiopharmaceuticals as precision medicines. The company has developed the Targeted Alpha Therapy (TAT) platform, as well as proprietary Fast-Clear connector technology, capable of connecting alpha-particle-emitting isotopes with antibodies and other targeted molecules to selectively deliver alpha-particle payloads to tumors. The company's TAT platform is based on research and insight into the basic biology of α-emitting radiopharmaceuticals and differentiated capabilities in target identification, candidate generation, manufacturing and supply chain, and imaging diagnostic development.
